Coming off the end of a large patent cliff, the schizophrenia market is estimated to be worth $5.2bn in the seven major markets in 2012 (the US, Japan, France, Germany, Italy, Spain, and the UK). Ongoing US price increases and atypical antipsychotic depots will stabilize the market in the medium term, while the fate of novel oral drugs will govern the future direction of the schizophrenia market....More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Alison
00 1 718 618 48 97
"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...
Actonel (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Actonel (Osteoporosis) - Forecast and Market Analysis to 2022?. ...
REPORT SCOPE INTRODUCTION REASONS FOR DOING THE STUDY The spread of human immunodeficiency virus (HIV), hepatitis B and C, evolving influenza strains and antibiotic-resistant organisms have put healthcare ...
... Reduce respiratory depression Long-acting profile Properties inherent to molecule source: ims midas; resources global chronic pain therapy market received fast track status from fda ...
... Associated urinary tract infection (cauti) outcome measure (nqf #0138) rti international measures application partnership (map) The measure applications partnership is a public- private partnership ...
Reportlinker.com © Copyright 2013. All rights reserved.